Annual Accounts Payable
$194.00 K
-$6.22 M-96.98%
31 December 2022
Summary:
Catalyst Biosciences annual accounts payable is currently $194.00 thousand, with the most recent change of -$6.22 million (-96.98%) on 31 December 2022. During the last 3 years, it has fallen by -$6.22 million (-96.98%).CBIO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$158.00 K
+$153.00 K+3060.00%
30 September 2023
Summary:
Catalyst Biosciences quarterly accounts payable is currently $158.00 thousand, with the most recent change of +$153.00 thousand (+3060.00%) on 30 September 2023.CBIO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -97.0% | -97.5% |
| 5 y5 years | -95.5% | -96.3% |
CBIO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -97.0% | -97.5% |
Catalyst Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $158.00 K(+3060.0%) |
| June 2023 | - | $5000.00(-68.8%) |
| Mar 2023 | - | $16.00 K(-91.8%) |
| Dec 2022 | $194.00 K(-97.0%) | $194.00 K(+373.2%) |
| Sept 2022 | - | $41.00 K(-96.0%) |
| June 2022 | - | $1.04 M(-78.0%) |
| Mar 2022 | - | $4.71 M(-26.7%) |
| Dec 2021 | $6.42 M(+8.2%) | $6.42 M(+66.2%) |
| Sept 2021 | - | $3.86 M(+110.6%) |
| June 2021 | - | $1.83 M(-38.0%) |
| Mar 2021 | - | $2.96 M(-50.2%) |
| Dec 2020 | $5.93 M(+38.6%) | $5.93 M(+39.8%) |
| Sept 2020 | - | $4.24 M(+183.1%) |
| June 2020 | - | $1.50 M(+13.9%) |
| Mar 2020 | - | $1.32 M(-69.2%) |
| Dec 2019 | $4.28 M(+242.9%) | $4.28 M(+101.6%) |
| Sept 2019 | - | $2.12 M(+440.2%) |
| June 2019 | - | $393.00 K(+39.4%) |
| Mar 2019 | - | $282.00 K(-77.4%) |
| Dec 2018 | $1.25 M(+67.1%) | $1.25 M(+238.2%) |
| Sept 2018 | - | $369.00 K(+175.4%) |
| June 2018 | - | $134.00 K(-90.7%) |
| Mar 2018 | - | $1.44 M(+92.4%) |
| Dec 2017 | $747.00 K(-10.8%) | $747.00 K(-48.8%) |
| Sept 2017 | - | $1.46 M(+191.4%) |
| June 2017 | - | $501.00 K(-44.3%) |
| Mar 2017 | - | $899.00 K(+7.4%) |
| Dec 2016 | $837.00 K(-10.9%) | $837.00 K(+58.2%) |
| Sept 2016 | - | $529.00 K(-36.0%) |
| June 2016 | - | $826.00 K(+15.2%) |
| Mar 2016 | - | $717.00 K(-23.6%) |
| Dec 2015 | $939.00 K(+131.9%) | $939.00 K(+40.4%) |
| Sept 2015 | - | $669.00 K(+92.8%) |
| June 2015 | - | $347.00 K(-70.8%) |
| Mar 2015 | - | $1.19 M(+193.6%) |
| Dec 2014 | $405.00 K | $405.00 K(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $364.00 K(-57.3%) |
| June 2014 | - | $853.00 K(-26.3%) |
| Mar 2014 | - | $1.16 M(-10.6%) |
| Dec 2013 | $1.30 M(-37.0%) | $1.30 M(-37.5%) |
| Sept 2013 | - | $2.08 M(-6.0%) |
| June 2013 | - | $2.21 M(-12.3%) |
| Mar 2013 | - | $2.52 M(+22.4%) |
| Dec 2012 | $2.06 M(-41.1%) | $2.06 M(+21.7%) |
| Sept 2012 | - | $1.69 M(-31.0%) |
| June 2012 | - | $2.45 M(+58.9%) |
| Mar 2012 | - | $1.54 M(-55.8%) |
| Dec 2011 | $3.49 M(-26.1%) | $3.49 M(+145.2%) |
| Sept 2011 | - | $1.42 M(-11.2%) |
| June 2011 | - | $1.60 M(-55.5%) |
| Mar 2011 | - | $3.60 M(-23.7%) |
| Dec 2010 | $4.72 M(+270.3%) | $4.72 M(-25.1%) |
| Sept 2010 | - | $6.31 M(+111.3%) |
| June 2010 | - | $2.98 M(-27.6%) |
| Mar 2010 | - | $4.12 M(+223.2%) |
| Dec 2009 | $1.27 M(-15.0%) | $1.27 M(-39.3%) |
| Sept 2009 | - | $2.10 M(+4.9%) |
| June 2009 | - | $2.00 M(+81.1%) |
| Mar 2009 | - | $1.11 M(-26.3%) |
| Dec 2008 | $1.50 M(-34.7%) | $1.50 M(-19.8%) |
| Sept 2008 | - | $1.87 M(+6.2%) |
| June 2008 | - | $1.76 M(+8.8%) |
| Mar 2008 | - | $1.62 M(-29.4%) |
| Dec 2007 | $2.30 M(+15.8%) | $2.30 M(-1.2%) |
| Sept 2007 | - | $2.32 M(+3.7%) |
| June 2007 | - | $2.24 M(+35.6%) |
| Mar 2007 | - | $1.65 M(-16.6%) |
| Dec 2006 | $1.98 M(+68.9%) | $1.98 M(+64.1%) |
| Sept 2006 | - | $1.21 M(-5.2%) |
| June 2006 | - | $1.27 M(+17.5%) |
| Mar 2006 | - | $1.08 M(-7.6%) |
| Dec 2005 | $1.17 M(-36.7%) | $1.17 M |
| Dec 2004 | $1.85 M | - |
FAQ
- What is Catalyst Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Catalyst Biosciences?
What is Catalyst Biosciences annual accounts payable?
The current annual accounts payable of CBIO is $194.00 K
What is the all time high annual accounts payable for Catalyst Biosciences?
Catalyst Biosciences all-time high annual accounts payable is $6.42 M
What is Catalyst Biosciences quarterly accounts payable?
The current quarterly accounts payable of CBIO is $158.00 K
What is the all time high quarterly accounts payable for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly accounts payable is $6.42 M